...
首页> 外文期刊>Scandinavian journal of infectious diseases. >A 10-year survey of blood culture negative endocarditis in Sweden: Aminoglycoside therapy is important for survival.
【24h】

A 10-year survey of blood culture negative endocarditis in Sweden: Aminoglycoside therapy is important for survival.

机译:瑞典一项为期10年的血液培养阴性心内膜炎调查:氨基糖苷类疗法对生存至关重要。

获取原文
获取原文并翻译 | 示例
           

摘要

We estimated the prevalence of blood culture negative endocarditis (CNE) and described and analysed data with special attention to antibiotic treatment from patients with infective endocarditis (IE) reported to the Swedish endocarditis registry during the 10-y period 1995-2004. All 29 departments of infectious diseases in Sweden reported data to the registry. During the 10-y period, 2509 IE episodes (78% Duke definite) were identified in 2410 patients. 304 CNE episodes (25% Duke definite) were found. The proportion of CNE was measured to be 12% of all IE episodes. Fatal outcome occurred in 10.7% of all IE patients and in 5% of the CNE patients. The risk of dying was significantly increased in female (9%) compared to male (2%) CNE patients (OR 5.1). Mortality was significantly decreased in patients treated with an aminoglycoside (3%) versus patients without aminoglycoside therapy (13%), OR 0.2. In conclusion, the prevalence of CNE was 12% in Swedish IE patients in a 10-y survey. The mortality in IE was low (10.7%) and 4.6% for CNE. Women have higher mortality rates than men in CNE. CNE patients who received aminoglycoside therapy survived more frequently than CNE patients without this therapy.
机译:我们估算了血液培养阴性心内膜炎(CNE)的患病率,并特别描述和分析了数据,这些数据特别关注感染性心内膜炎(IE)患者在1995-2004十年期间向瑞典心内膜炎登记中心报告的抗生素治疗情况。瑞典所有29个传染病部门均向登记处报告了数据。在10年期间,在2410例患者中发现了2509例IE发作(确定为Duke的78%)。发现304次CNE事件(定为25%的杜克大学)。据测,CNE的比例为所有IE事件的12%。致命结果发生在所有IE患者中10.7%和CNE患者中5%。与男性(2%)的CNE患者相比,女性(9%)的死亡风险显着增加(OR 5.1)。与未使用氨基糖苷治疗的患者(13%)相比,使用氨基糖苷治疗的患者(3%)的死亡率显着降低。总之,在一项为期10年的调查中,瑞典IE患者中CNE的患病率为12%。 IE中的死亡率很低(10.7%),CNE的死亡率为4.6%。在CNE,女性的死亡率高于男性。接受氨基糖苷疗法的CNE患者比未接受该疗法的CNE患者存活率更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号